See more : NV5 Global, Inc. (NVEE) Income Statement Analysis – Financial Results
Complete financial analysis of Fufeng Group Limited (0546.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fufeng Group Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- AARNAV FASHIONS LIMITED (AARNAV.BO) Income Statement Analysis – Financial Results
- Medexus Pharmaceuticals Inc. (MDP.TO) Income Statement Analysis – Financial Results
- BBGI Public Company Limited (BBGI.BK) Income Statement Analysis – Financial Results
- Izotropic Corporation (IZO.CN) Income Statement Analysis – Financial Results
- Nam Liong Global Corporation (5450.TWO) Income Statement Analysis – Financial Results
Fufeng Group Limited (0546.HK)
About Fufeng Group Limited
Fufeng Group Limited, an investment holding company, engages in the manufacture and sale of fermentation-based food additive, and biochemical and starch-based products in the People's Republic of China and internationally. It operates through Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and Other segments. The Food Additives segment manufactures and sells monosodium glutamate, starch sweeteners, glutamic acid, compound seasoning, and corn oil. The Animal Nutrition segment manufactures and sells corn refined products, threonine, and lysine. The High-End Amino Acid segment offers high-end amino acid products. The Colloid segment provides xanthan and gellan gum products. The Other segment offers fertilisers, synthetic ammonia, pharmaceuticals, and other products. It also engages in the manufacture and sale of autoclaved aerated concrete blocks, eubacteria material medicine, preparations and food additives, bricks, and other related products; research and development, promotion, and industrialization of new biological techniques and achievements; sale of cosmetics, biological products, and health food and other related products; and provision of logistics and equity investment services, as well as information services of biological techniques. Fufeng Group Limited was founded in 1999 and is based in Linyi, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.01B | 27.47B | 21.54B | 16.69B | 16.17B | 13.76B | 13.03B | 11.80B | 11.23B | 11.30B | 11.37B | 11.11B | 8.40B | 6.42B | 4.63B | 3.59B | 2.45B | 1.79B |
| Cost of Revenue | 21.76B | 20.26B | 17.63B | 13.87B | 12.91B | 11.19B | 10.08B | 9.28B | 9.42B | 9.13B | 9.27B | 9.47B | 6.88B | 4.85B | 3.23B | 2.94B | 2.20B | 1.43B |
| Gross Profit | 6.25B | 7.21B | 3.91B | 2.82B | 3.26B | 2.57B | 2.95B | 2.53B | 1.80B | 2.17B | 2.10B | 1.64B | 1.52B | 1.57B | 1.40B | 644.33M | 249.67M | 355.14M |
| Gross Profit Ratio | 22.31% | 26.25% | 18.13% | 16.87% | 20.16% | 18.71% | 22.67% | 21.40% | 16.06% | 19.18% | 18.47% | 14.74% | 18.09% | 24.39% | 30.21% | 17.97% | 10.21% | 19.87% |
| Research & Development | 375.01M | 382.08M | 386.96M | 324.69M | 338.49M | 228.46M | 66.17M | 47.99M | 64.21M | 62.04M | 129.27M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.20B | 1.04B | 939.23M | 806.26M | 812.03M | 658.51M | 482.84M | 482.87M | 496.50M | 445.36M | 531.91M | 440.14M | 373.70M | 277.70M | 194.91M | 141.96M | 113.71M | 40.53M |
| Selling & Marketing | 1.80B | 1.76B | 1.40B | 1.38B | 1.33B | 1.04B | 981.51M | 816.60M | 708.93M | 706.24M | 710.27M | 570.49M | 421.33M | 272.01M | 215.72M | 166.41M | 104.16M | 61.81M |
| SG&A | 3.01B | 2.80B | 2.37B | 2.21B | 2.15B | 1.70B | 1.49B | 1.33B | 1.22B | 1.16B | 1.25B | 1.01B | 795.03M | 549.71M | 410.63M | 308.37M | 217.87M | 102.34M |
| Other Expenses | -832.89M | 20.31M | -9.81M | 0.00 | -90.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -86.05M | -53.32M | -88.36M | -59.87M | 0.00 | 66.00K | -2.37M |
| Operating Expenses | 2.55B | 2.21B | 2.25B | 1.88B | 1.76B | 209.46M | 1.20B | 1.05B | 870.77M | 1.07B | 1.10B | 924.58M | 741.71M | 461.34M | 350.76M | 308.37M | 217.93M | 99.97M |
| Cost & Expenses | 24.31B | 22.48B | 19.89B | 15.76B | 14.67B | 11.40B | 11.28B | 10.33B | 10.29B | 10.20B | 10.37B | 10.40B | 7.62B | 5.31B | 3.58B | 3.25B | 2.41B | 1.53B |
| Interest Income | 330.50M | 137.73M | 136.44M | 162.41M | 98.04M | 154.49M | 102.19M | 171.69M | 252.00M | 324.85M | 360.23M | 6.23M | 10.06M | 0.00 | 0.00 | 0.00 | 53.34M | 6.56M |
| Interest Expense | 165.05M | 238.50M | 172.71M | 206.06M | 201.16M | 170.31M | 109.17M | 181.15M | 266.42M | 337.46M | 367.18M | 257.24M | 61.53M | 32.38M | 25.25M | 42.66M | 47.38M | 20.37M |
| Depreciation & Amortization | 1.12B | 1.16B | 1.24B | 1.25B | 1.16B | 1.06B | 893.65M | 854.08M | 746.89M | 707.13M | 690.32M | 533.15M | 368.28M | 253.95M | 193.31M | 154.77M | 116.95M | 55.00M |
| EBITDA | 5.14B | 6.26B | 2.89B | 2.11B | 2.69B | 2.10B | 2.60B | 2.36B | 1.72B | 1.80B | 1.63B | 1.26B | 1.15B | 1.36B | 1.24B | 522.82M | 209.48M | 316.74M |
| EBITDA Ratio | 18.35% | 21.54% | 13.43% | 12.63% | 16.66% | 15.29% | 19.93% | 20.00% | 15.33% | 15.96% | 14.38% | 11.38% | 13.65% | 21.16% | 26.81% | 14.58% | 8.26% | 17.72% |
| Operating Income | 3.70B | 4.79B | 1.67B | 879.81M | 1.56B | 1.07B | 1.73B | 1.53B | 973.75M | 1.10B | 944.56M | 735.08M | 777.97M | 1.10B | 1.05B | 335.96M | 47.85M | 264.65M |
| Operating Income Ratio | 13.21% | 17.42% | 7.78% | 5.27% | 9.65% | 7.75% | 13.27% | 13.00% | 8.67% | 9.70% | 8.31% | 6.62% | 9.26% | 17.20% | 22.64% | 9.37% | 1.96% | 14.81% |
| Total Other Income/Expenses | 150.77M | -390.44M | -64.38M | -25.84M | -153.42M | 1.14B | -62.01M | -208.52M | -353.70M | -333.60M | -290.30M | -244.87M | -61.53M | -32.38M | -25.25M | -42.66M | 13.68M | -14.85M |
| Income Before Tax | 3.85B | 4.86B | 1.52B | 770.64M | 1.40B | 2.21B | 1.65B | 1.30B | 679.77M | 774.18M | 634.70M | 490.21M | 716.44M | 1.07B | 1.02B | 325.38M | 45.49M | 249.81M |
| Income Before Tax Ratio | 13.75% | 17.69% | 7.04% | 4.62% | 8.65% | 16.06% | 12.68% | 11.03% | 6.06% | 6.85% | 5.58% | 4.41% | 8.53% | 16.70% | 22.09% | 9.08% | 1.86% | 13.98% |
| Income Tax Expense | 706.12M | 999.23M | 235.33M | 140.74M | 262.04M | 365.78M | 270.40M | 209.39M | 163.51M | 147.75M | 128.57M | 63.66M | 112.30M | 105.28M | 95.31M | 30.67M | 416.00K | 9.33M |
| Net Income | 3.14B | 3.86B | 1.28B | 629.90M | 1.14B | 1.85B | 1.38B | 1.09B | 516.26M | 626.43M | 506.13M | 426.55M | 604.14M | 966.05M | 928.29M | 294.71M | 45.07M | 240.48M |
| Net Income Ratio | 11.23% | 14.05% | 5.95% | 3.77% | 7.03% | 13.40% | 10.61% | 9.26% | 4.60% | 5.54% | 4.45% | 3.84% | 7.19% | 15.06% | 20.04% | 8.22% | 1.84% | 13.46% |
| EPS | 1.24 | 1.52 | 0.51 | 0.25 | 0.45 | 0.72 | 0.57 | 0.51 | 0.24 | 0.30 | 0.25 | 0.22 | 0.33 | 0.54 | 0.53 | 0.17 | 0.03 | 0.19 |
| EPS Diluted | 1.24 | 1.52 | 0.51 | 0.25 | 0.45 | 0.72 | 0.55 | 0.48 | 0.24 | 0.29 | 0.22 | 0.22 | 0.32 | 0.51 | 0.53 | 0.17 | 0.03 | 0.19 |
| Weighted Avg Shares Out | 2.54B | 2.53B | 2.53B | 2.53B | 2.54B | 2.55B | 2.42B | 2.41B | 2.40B | 2.39B | 2.29B | 1.97B | 2.03B | 1.95B | 1.76B | 1.76B | 1.71B | 1.27B |
| Weighted Avg Shares Out (Dil) | 2.54B | 2.54B | 2.53B | 2.53B | 2.54B | 2.55B | 2.50B | 2.41B | 2.40B | 2.39B | 2.32B | 1.97B | 2.03B | 1.95B | 1.76B | 1.76B | 1.71B | 1.27B |
Source: https://incomestatements.info
Category: Stock Reports